Karen Schoedel

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
The Role of AXL Signaling and Mutant Isocitrate Dehydrogenase 1/2 in Conventional Chondrosarcoma.

|Dec 09, 2024
Low-grade myxoid spindle cell neoplasm with novel gene fusions involving MAP3K3 and MAP3K8 kinases: a report of two cases.

Azfar Neyaz, Mana Mohebnasab, Elan Hahn

|Dec 04, 2024
Rapidly enlarging ACTIN::MITF rearranged clear cell tumour with melanocytic differentiation.

Nathaniel J Bigot, Azfar Neyaz, Rana Naous

|Jul 30, 2024
Novel dual gene fusions identified in a late pulmonary metastasis of an infantile fibrosarcoma-like tumor.

Karen Schoedel, Shaymaa Hegazy, Megan L Zilla

|Mar 26, 2024
Postoperative infection and bone sarcoma survival: systematic review of the role of infection in bone sarcoma prognosis.

Sean W Dooley, Matthew F Gong, Luke A Carlson

|Jan 23, 2024
Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy.

Karen Schoedel, Tanya Heim, Anette Duensing

Pageof 2

Frequent Collaborators

2 joint publications

Rana Naous

2 joint publications

Azfar Neyaz

1 joint publications

Matthew F Gong

1 joint publications

Luke A Carlson